Skip to main content
HOUSE OF COMMONS OF CANADA
35th PARLIAMENT, 2nd SESSION


EVIDENCE

Standing Committee
on

INDUSTRY

Chairman: David Walker, Lib.

Meeting No. 59

Tuesday, April 8, 1997


ORDER OF THE DAY:

Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)

WITNESSES:

Board of Trade of Metropolitan Toronto:

David McFadden, Vice-President.

Canadian Pharmaceutical Association:

Garry Cruickshank, Vice-President;

Noëlle-Dominique Willems, Director of Government and Public Affairs.

Chamber of Commerce of Montreal:

Luc Lacharité, Executive Vice-President.

Grey Clark Shih and Associates:

Peter Clark, President.

Groupement provincial de l'industrie du médicament:

Pierre Morin.

Map International of Canada:

John P. Kelsall, President;

Robert Stephens, Member.

Novopharm Limited:

David Howard, President, Stanley Pharmaceuticals Ltd.;

Jacques Messier, President and Chief Operating Officer;

David Windross, Director, Government and Professional Affairs.

New Democratic Party:

Alexa McDonough, Leader;

Stephen Shrybman, Policy Analyst.

Quebec Research Group on Medication Use on the Elderly:

Robyn Tamblyn.

University of British Columbia:

James Wright, Department of Pharmacology and Therapeutics.

Click here to view Committee Evidence

;